Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn

被引:127
作者
Cheng, HY
Lin, CC
Lin, TC
机构
[1] Kaohsiung Med Univ, Coll Pharm, Grad Inst Pharmaceut Sci, Kaohsiung 807, Taiwan
[2] Ta Jen Inst Technol, Dept Pharm, Pingtung, Taiwan
关键词
Terminalia arjuna Linn; casuarinin; anti-HSV-2; activity; hydrolyzable tannin; Combretaceae;
D O I
10.1016/S0166-3542(02)00077-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Casuarinin, a hydrolyzable tannin isolated from the bark of Terminalia arjuna Linn. (Combretaceae), was investigated for its antiviral activity on herpes simplex type 2 (HSV-2) in vitro. Results showed that the IC50 Of casuarinin in XTT and plaque reduction assays were 3.6 +/- 0.9 and 1.5 +/- 0.2 muM, respectively. The 50% cytotoxic concentration for cell growth (CC50) was 89 +/- 1 muM. Thus, the selectivity index (SI) (ratio Of CC50 to IC50) of casuarinin was 25 and 59 for XTT and plaque reduction assays, respectively. Casuarinin continued to exhibit antiviral activity even added 12 h after infection. During the attachment assay, casuarinin was shown to prevent the attachment of HSV-2 to cells. Furthermore, casuarinin also exhibited an activity in inhibiting the viral penetration. Interestingly, casuarinin was virucidal at a concentration of 25 muM, reducing viral titers up to 100,000-fold. This study concludes that casuarinin possesses anti-herpesvirus activity in inhibiting viral attachment and penetration, and also disturbing the late event(s) of infection. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:447 / 455
页数:9
相关论文
共 32 条
[1]   SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2 [J].
Albin, R ;
Chase, R ;
Risano, C ;
Lieberman, M ;
Ferrari, E ;
Skelton, A ;
Buontempo, P ;
Cox, S ;
DeMartino, J ;
WrightMinogue, J ;
JirauLucca, G ;
Kelly, J ;
Afonso, A ;
Kwong, AD ;
Rozhon, EJ ;
OConnell, JF .
ANTIVIRAL RESEARCH, 1997, 35 (03) :139-146
[2]   RECOVERY OF HERPES-SIMPLEX VIRUS FROM HUMAN TRIGEMINAL GANGLIONS [J].
BARINGER, JR ;
SWOVELAND, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (13) :648-650
[3]   ANTIVIRAL THERAPY - CURRENT CONCEPTS AND PRACTICES [J].
BEAN, B .
CLINICAL MICROBIOLOGY REVIEWS, 1992, 5 (02) :146-182
[4]   Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection [J].
Boulware, SL ;
Bronstein, JC ;
Nordby, EC ;
Weber, PC .
ANTIVIRAL RESEARCH, 2001, 51 (02) :111-125
[5]   Antiherpetic activity and mode of action of natural carrageenans of diverse structural types [J].
Carlucci, MJ ;
Ciancia, M ;
Matulewicz, MC ;
Cerezo, AS ;
Damonte, EB .
ANTIVIRAL RESEARCH, 1999, 43 (02) :93-102
[6]   New therapeutic approaches to the alphaherpesvirus infections [J].
Cassady, KA ;
Whitley, RJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :119-128
[7]   Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis is essential oil [J].
De Logu, A ;
Loy, G ;
Pellerano, ML ;
Bonsignore, L ;
Schivo, ML .
ANTIVIRAL RESEARCH, 2000, 48 (03) :177-185
[8]   HERPES-SIMPLEX VIRUS RESISTANT TO ACYCLOVIR - A STUDY IN A TERTIARY CARE CENTER [J].
ENGLUND, JA ;
ZIMMERMAN, ME ;
SWIERKOSZ, EM ;
GOODMAN, JL ;
SCHOLL, DR ;
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :416-422
[9]   ACYCLOVIR-RESISTANT HERPES-SIMPLEX VIRUS-INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ERLICH, KS ;
MILLS, J ;
CHATIS, P ;
MERTZ, GJ ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GRANT, RM ;
CRUMPACKER, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :293-296
[10]   INHIBITION OF HERPES-SIMPLEX VIRUS-INFECTION BY TANNINS AND RELATED-COMPOUNDS [J].
FUKUCHI, K ;
SAKAGAMI, H ;
OKUDA, T ;
HATANO, T ;
TANUMA, S ;
KITAJIMA, K ;
INOUE, Y ;
INOUE, S ;
ICHIKAWA, S ;
NONOYAMA, M ;
KONNO, K .
ANTIVIRAL RESEARCH, 1989, 11 (5-6) :285-297